A pathophysiology flow diagram illustrating the immunological cascade from severe burn injury to the development of sepsis. The diagram begins with a burn injury, represented by illustrations of first-, second-, and third-degree burns on a hand, leading to the systemic release of Damage-Associated Molecular Patterns (DAMPs) and Pathogen-Associated Molecular Patterns (PAMPs), specifically citing HMGB1, mitochondrial LNA, dsRNA, and LPS. This initiates a complex immune and inflammatory response characterized by three convergent pathways: 1) Pro-inflammatory and anti-inflammatory cytokine imbalances (increased IL-6, IL-10, TNF, and PGE) alongside reduced Class II MHC expression and antigen presentation, leading to immunosuppression. 2) Impaired innate cellular function, specifically decreased phagocytosis and bactericidal activity. 3) Th2-skewed cytokine shifts (increased IL-4 and IL-10; decreased IL-2 and IFN̲γ) and reduced lymphocyte proliferation, promoting bacterial multiplication. These combined dysregulated host responses ultimately culminate in burn-induced sepsis.

A medical illustration detailing the pathophysiology of SARS-CoV-2 infection leading to cytokine storm and multi-organ dysfunction syndrome (MODS). The left panel outlines a cellular pathway: infection of epithelial cells triggers ROS production, cell death, and activation of NLRP3 and NF-κB. This leads to an 'immune invasion' involving macrophages, neutrophils, and T cells, which release pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNFα/γ). The resulting 'cytokine storm' drives an inflammatory cascade toward ARDS, sepsis, and MODS. A parallel pathway links PAMPs/DAMPs and PRR activation directly to tissue damage. The right panel displays organ-specific clinical manifestations: neurologic (anosmia, impaired consciousness), cardiovascular (chest tightness, heart attack), respiratory (dyspnoea, dry cough), gastrointestinal (vomiting, nausea), renal (haematuria, oliguria), and hepatic (raised AST). The progression culminates in a terminal stage labeled 'Death.' The diagram is designed for intermediate medical education, emphasizing the systemic inflammatory nature of COVID-19.

This pathophysiology diagram illustrates the sequential progression of endothelial cell damage and immune activation during sepsis. The process begins with 'Septic Status' leading to (1) increased IL-6 in the blood (blue dots). This triggers (2) the release of PAI-1 (red triangles), affecting the endothelium. (3) Endothelial cell damage is represented by a color transition from healthy blue-outlined cells to red-outlined (intermediate damage) and finally black-outlined/solid black cells (severe damage). This cellular injury leads to (4) the activation of tissue-resident dendritic cells (DC) and (5) a trigger for a massive cytokine storm, visualized as a dense cluster of multi-colored symbols. The cumulative effect of the endothelial dysfunction and cytokine release culminates in (6) septic shock or further critical status such as Disseminated Intravascular Coagulation (DIC). The diagram emphasizes the maintenance role of endothelial cells in cytokine signaling pathways and the development of coagulation system disorders.

A medical pathophysiology diagram illustrating three primary routes by which cytokines and inflammatory signals enter the brain from the systemic circulation, specifically in the context of sepsis. Route I (Humoral mechanism) depicts the breakdown of the blood-brain barrier (BBB), showing capillary endothelial cells with disrupted tight junctions, allowing T cells, B cells, and cytokines to leak into the parenchyma near astrocytes and neurons. Route II (Cellular route) details the infiltration of peripheral immune cells, including neutrophils and macrophages, and the activation of cerebral endothelial cells (ECs). This section highlights the transition of resting microglia to activated microglia, mediated by DAMPs and proteinase-3, leading to the release of pro-inflammatory mediators such as TNF-alpha, iNOS, interleukins (IL-1, IL-6/12/23), and various chemokines (CXCL and CCL families). Route III (Neural route) illustrates the transmission of cytokine signals via autonomic nerve fibers and cytokine receptors, particularly affecting the hypothalamus, brainstem nuclei (nucleus solitarius), amygdala, and hippocampus. The central illustration provides anatomical context within a sagittal view of the human brain, mapping these pathways to specific neuroanatomical structures.

Summary : This figure presents recommendations for hemodynamic management in adults with sepsis or septic shock, focusing on the use of various fluids for resuscitation. It includes five guideline statements, each with a strength of recommendation, quality of evidence, and relevant 2016 statements for comparison. flowchart/table hybrid: # Recommendations Overview : • Five numbered recommendations (32–36) for fluid resuscitation in sepsis/septic shock. • Each recommendation includes: strength (recommend/suggest/suggest against/recommend against), evidence quality (moderate, low, high), and a traffic light icon (green/yellow/red). • 2016 statements are provided for two recommendations for historical comparison. # Individual Recommendations : • 32 (Moderate, green): "For adults with sepsis or septic shock, we recommend using crystalloids as first-line fluid for resuscitation." • 33 (Low, yellow): "For adults with sepsis or septic shock, we suggest using balanced crystalloids instead of normal saline for resuscitation." – 2016 Statement: "We suggest using either balanced crystalloids or saline for fluid resuscitation of patients with sepsis or septic shock." • 34 (Moderate, yellow): "For adults with sepsis or septic shock, we suggest using albumin in patients who received large volumes of crystalloids." • 35 (High, red): "For adults with sepsis or septic shock, we recommend against using starches for resuscitation." • 36 (Moderate, red): "For adults with sepsis and septic shock, we suggest against using gelatin for resuscitation." – 2016 Statement: "We suggest using crystalloids over gelatins when resuscitating patients with sepsis or septic shock." # Design Encodings : • Traffic light icons (green, yellow, red) indicate recommendation strength. • Horizontal bar visual for evidence quality (moderate, low, high). • Blue highlight for 2016 statements. • Bold text for "recommend" and "suggest" actions. # Analysis : • Crystalloids are strongly recommended as first-line fluids (moderate evidence). • Balanced crystalloids are suggested over saline, but evidence is low. • Albumin is suggested only for patients needing large volumes of crystalloids. • Starches and gelatins are discouraged, with strong (high) evidence against starches and moderate evidence against gelatins. • Recommendations have evolved slightly since 2016, with more explicit discouragement of gelatins and starches.

Summary : This figure presents a summary of recommendations for the management of vasoactive agents in patients with septic shock, focusing on the choice and administration of vasopressors, monitoring strategies, and adjustments for cardiac dysfunction. flowchart: # Nodes : • "Use norepinephrine as first-line vasopressor" (rounded rectangle, strong recommendation) • "Target a MAP of 65mm Hg" (rounded rectangle, strong recommendation) • "Consider invasive monitoring of arterial blood pressure" (rounded rectangle, strong recommendation) • "Consider initiating vasopressors peripherally*" (rounded rectangle, weak recommendation) • "Consider adding vasopressin" (rounded rectangle, weak recommendation) • "Consider adding dobutamine or switching to epinephrine" (rounded rectangle, weak recommendation) # Connectors : • "For patients with septic shock on vasopressor" leads to three nodes: norepinephrine use, MAP target, and invasive monitoring. • "If central access is not yet available" leads to "Consider initiating vasopressors peripherally*". • "If MAP is inadequate despite low-to-moderate-dose norepinephrine" leads to "Consider adding vasopressin". • "If cardiac dysfunction with persistent hypoperfusion is present despite adequate volume status and blood pressure" leads to "Consider adding dobutamine or switching to epinephrine". # Layout : • Three main columns: – Left: Initial management for septic shock (norepinephrine, MAP target, invasive monitoring). – Middle: Adjustments if central access is unavailable or MAP is inadequate (peripheral vasopressors, add vasopressin). – Right: Management for cardiac dysfunction (add dobutamine or switch to epinephrine). • Recommendations are visually distinguished by icons: green for strong, yellow for weak. • Footnote: Peripheral vasopressors should be administered only for a short period and in a vein proximal to the antecubital fossa. # Analysis : • The figure prioritizes norepinephrine as the first-line vasopressor and a MAP target of 65mm Hg, both as strong recommendations. • Invasive monitoring is also strongly recommended. • Weak recommendations address practical adjustments: peripheral administration if central access is delayed, adding vasopressin if MAP remains low, and using dobutamine or epinephrine for cardiac dysfunction. • The flowchart structure supports stepwise escalation and adaptation based on patient response and access limitations.

Summary : This figure presents recommendations and evidence levels for vasopressor and fluid management in adults with septic shock, using a combination of iconography, colour-coded evidence bars, and textual statements. table-figure hybrid: # Recommendation Structure : • Each numbered recommendation (37–45) is accompanied by a coloured evidence bar (green = high, yellow = moderate, orange = low, grey = very low). • Icons indicate recommendation strength: exclamation mark (suggest/recommend), red exclamation (suggest against), question mark (insufficient evidence). • Recommendations are grouped by drug or intervention type (vasopressors, monitoring, fluid strategy). # Vasopressor Agents : • Norepinephrine is recommended as first-line agent (high evidence). • Dopamine, vasopressin, epinephrine, selepressin, angiotensin 2 are listed with respective evidence levels (high to very low). • Vasopressin is suggested to be added if norepinephrine is inadequate (moderate evidence). • Epinephrine is suggested to be added if both norepinephrine and vasopressin are inadequate (low evidence). • Terlipressin and levosimendan are suggested against (low evidence). # Cardiac Dysfunction Management : • For persistent hypoperfusion, dobutamine or epinephrine may be added (low evidence). • Levosimendan is suggested against (low evidence). # Monitoring and Administration : • Invasive monitoring of arterial blood pressure is suggested over non-invasive methods when resources allow (very low evidence). • Starting vasopressors peripherally is suggested rather than delaying for central access (very low evidence). # Fluid Resuscitation : • No recommendation on restrictive vs. liberal fluid strategies due to insufficient evidence. • 2016 statement: balanced crystalloids or saline suggested for resuscitation; crystalloids preferred over gelatins. # Design Encodings : • Evidence bars: green (high), yellow (moderate), orange (low), grey (very low). • Icons: exclamation mark (suggest/recommend), red exclamation (suggest against), question mark (insufficient evidence). • Textual recommendations are bolded for "recommend" and "suggest". # Analysis : • Norepinephrine is strongly favoured as first-line vasopressor. • Vasopressin and epinephrine are considered as adjuncts if initial therapy fails. • Several agents (terlipressin, levosimendan) are specifically discouraged. • Invasive monitoring and peripheral vasopressor initiation are suggested despite low evidence. • Fluid strategy remains an area of uncertainty, with prior guidance favouring crystalloids.

Table 7: Definition and criteria of sepsis and septic shock [304-306] <table><thead><tr><th>Disorder</th><th>Definition</th></tr></thead><tbody><tr><td>Sepsis</td><td>Life-threatening organ dysfunction caused by a dysregulated host response to infection. For clinical application, organ dysfunction can be represented by an increase in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score of 2 points or more. For rapid identification a quickSOFA (qSOFA) score was developed: respiratory rate of 22/min or greater, altered mentation, or systolic blood pressure of 100 mmHg or less.</td></tr><tr><td>Septic shock</td><td>Septic shock should be defined as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Patients with septic shock can be clinically identified by a vasopressor requirement to maintain a mean arterial pressure of 65 mmHg or greater and serum lactate level greater than 2 mmol/L (>18 mg/dL) in the absence of hypovolemia.</td></tr></tbody></table>

This composite educational graphic details the Mottling Score system used to assess peripheral tissue perfusion, particularly in the context of sepsis and septic shock. Panel A features an anatomical diagram of a lower limb with red concentric ellipses illustrating the semi-quantitative scoring criteria (1–5) based on the anatomical extension of skin mottling. Score 1 is localized to the patella center; score 2 reaches the superior edge of the patella; score 3 extends to the mid-thigh; score 4 reaches the groin fold; and score 5 extends beyond the groin. Panel B is a clinical photograph of a patient's leg demonstrating a high mottling score (Stage 4-5). The skin shows diffuse, reticulated, purple-to-bluish discoloration (livedo reticularis) extending from the knee upward toward the thigh and downward to the pretibial area. This visual sign represents microcirculatory dysfunction and is used as a prognostic indicator for organ failure and mortality in critically ill patients.

A multi-panel comparison chart comprising six line graphs (A-F) tracking clinical severity scores and inflammatory biomarkers in ICU patients over a seven-week period. The data is stratified into two groups based on maximum nucleated red blood cell (nRBC) counts: >105 µl-1 (indicated by circles) and ≤105 µl-1 (indicated by squares). Graphs A, B, and C demonstrate that patients with higher nRBC counts consistently exhibit significantly higher disease severity scores, including the Sepsis-related Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation (APACHE) II, and Simplified Acute Physiology Score (SAPS) II. Graph D shows a significantly lower PaO2/FiO2 ratio (indicating worse pulmonary function) in the high nRBC group. Graphs E and F track Interleukin-6 and Procalcitonin levels, respectively; significant differences are primarily noted in the early ICU stay for Procalcitonin. Statistical significance is indicated by asterisks (*p < 0.05, **p < 0.01, ***p < 0.001) above weekly brackets. Vertical error bars represent data variability.

A clinical photograph of a printed arterial blood gas (ABG) analysis report. The document displays measured and calculated physiological values at a patient temperature of 37.0°C. Key measured values include a pH of 7.480, pCO2 of 22.3 mmHg, pO2 of 330.6 mmHg, and electrolyte levels (Na+ 143.4 mmol/L, K+ 3.28 mmol/L, Ca++ 1.03 mmol/L). Calculated values show a bicarbonate (HCO3-) level of 16.8 mmol/L and an oxygen saturation (SO2%) of 100.0%. This visual demonstrates a 'saturation gap' characteristic of certain toxicological conditions, such as methemoglobinemia, where the calculated oxygen saturation from the ABG appears normal (100%) despite the patient potentially experiencing clinical cyanosis and low peripheral pulse oximetry readings. The image is an educational tool for critical care, emergency medicine, and clinical toxicology, illustrating the interpretation of acid-base balance and oxygenation status.

Summary : This flowchart outlines the recommended process for initiating noninvasive ventilation (NIV) in patients with neuromuscular disease (NMD) who show symptoms of respiratory failure, using pulmonary function testing (PFT), overnight oximetry (ONO), arterial blood gas (ABG) analysis, and polysomnography (PSG) criteria. flowchart: # Nodes : • NMD (rectangle) – starting point. • PFT every 6 mo. Are criteria met?¹ (diamond) • Initiate NIV (rectangle) • Schedule follow-up PFT in 6 mo. Monitor for current symptoms.² Do symptoms exist? (diamond) • ONO or ABG testing. Are criteria met?³ (diamond) • Perform full polysomnography (PSG). Are criteria met?⁴ (diamond) # Connectors : • NMD → PFT every 6 mo. Are criteria met?¹ • If Yes → Initiate NIV • If No → Schedule follow-up PFT in 6 mo. Monitor for current symptoms.² Do symptoms exist? • If Yes → ONO or ABG testing. Are criteria met?³ • If Yes → Initiate NIV • If No → Perform full polysomnography (PSG). Are criteria met?⁴ • If Yes → Initiate NIV • If No → (no further action indicated in chart) # Criteria Boxes (side panels) : ## PFT Criteria : • FVC < 80% predicted with symptoms² or FVC < 50% predicted without symptoms • MIP < 60 cm H₂O or MEP < 40 cm H₂O • PCF < 270 L/min for age ≥ 12 y, PCF < 5th percentile for age < 12 y • SNIP < 70 cm H₂O in male patients, SNIP < 60 cm H₂O in female patients for age ≥ 12 y ## Symptoms : • Fatigue • Headache (especially morning) • Concentration difficulties • School/work performance difficulties • Memory changes • Shortness of breath • Weakness • Snoring/gasping/witnessed apneas • Pulmonary exacerbation requiring hospital admission ## ONO/ABG Criteria : • SpO₂ ≤ 90% for ≥ 2% of sleep time • PaCO₂ on ABG > 45 mm Hg • CBG in children as an alternative ## PSG Criteria : • Adults: – AHI ≥ 5 events/h – SpO₂ ≤ 88% for at least 5 min continuously • Pediatric Patients: – AHI ≥ 5 events/h – TcCO₂ or EtCO₂ ≥ 50 mm Hg for ≥ 2% of sleep time – Rise in TcCO₂ or EtCO₂ ≥ 10 mm Hg above awake baseline for ≥ 2% of sleep time – SpO₂ ≤ 90% for ≥ 2% of recording time or 5 min continuously # Layout : • Vertical flow from top (NMD) to bottom. • Decision diamonds branch to either next test or NIV initiation. • Side panels provide detailed criteria for each test or symptom. # Analysis : • The flowchart provides a stepwise, criteria-driven approach for NIV initiation in NMD patients. • It prioritizes PFT results, then symptoms, followed by ONO/ABG, and finally PSG if earlier criteria are not met. • The process ensures that patients with respiratory failure symptoms or abnormal test results are identified and treated with NIV, while those without clear criteria are monitored and retested. • The inclusion of detailed criteria for each test and symptom ensures standardized decision-making.

This medical anatomical diagram illustrates the arterial blood supply and vascular distribution patterns across the internal skull base, specifically focusing on feeders involved in skull base meningiomas. The composite image consists of five sub-figures (A-E) superimposed on a superior view of a human skull model. Sub-figure A depicts the Dorsal Meningeal Artery (DMA) in red, originating from the meningohypophyseal trunk and descending along the upper clivus. Sub-figure B shows the Ascending Pharyngeal Artery (APA) in orange, distributing around the foramen magnum and lower clivus. Sub-figure C highlights the Tentorial Artery (TA) in green, following the course of the tentorium cerebelli. Sub-figure D illustrates the Petrosal Branch (PB) in blue, arising from the middle meningeal artery near the foramen spinosum and reaching the petrous apex. Sub-figure E provides a summarized color-coded overlay demonstrating the spatial relationships of these four vascular territories relative to the clivus, petrous bone, and foramen magnum. This visual guide assists in identifying potential feeding arteries based on the tumor's dural attachment site during preoperative planning for meningioma resection.

Anatomical Diagram and intraoperative overlay illustrating the arterial blood supply to the cavernous sinus, specifically regarding the feeding vessels of skull base meningiomas. The cavernous sinus is highlighted by a pink outline. The arterial distribution is color-coded: the Tentorial Artery (TA) is represented in yellow, demonstrating its supply to the superolateral aspect of the posterior cavernous sinus. The Dural Meningeal Artery (DMA) is shown in blue, highlighting its coverage of the inferomedial portion of the posterior cavernous sinus. A red arrow identifies the interface where cranial nerves are typically situated between these two arterial territories. The image serves as a clinical reference for neurosurgical planning, helping to differentiate between petrotentorial and petroclival meningioma attachments based on their primary feeding arteries and their spatial relationship to critical neurovascular structures within the skull base.

This diagnostic imaging graphic illustrates metabolic cardiac imaging using hyperpolarized 13C MRI to measure intracellular myocardial pH. Panel (a) presents mid-ventricular cross-sectional slices from three subjects under 'Rest' and 'Stress' (dobutamine-induced) conditions. Four image types are displayed for each: 'Anatomical' (standard GRE reference), 'HCO3-' (bicarbonate distribution), 'CO2' (carbon dioxide distribution), and a derived 'pH' map. The pH maps utilize a color scale ranging from blue (pH 6) to red (pH 8). Visually, the 'Rest' maps show warmer colors (yellow/orange), indicating a physiological pH of approximately 7.2. Under 'Stress', there is a noticeable shift toward cooler colors (green/blue), representing myocardial acidification. Panel (b) is a statistical comparison graph showing a significant decrease in mean myocardial pH from approximately 7.15 at rest to 6.90 during stress (p < 0.05). This content demonstrates the use of metabolic imaging to monitor myocardial acid-base balance and response to increased cardiac workload, relevant to cardiovascular physiology and diagnostic radiology.

This composite educational graphic illustrates in vivo pH measurement within a MAT B III adenocarcinoma using hyperpolarized 13C Zymonic Acid (ZA). (a, b) Axial intensity maps show the accumulation of hyperpolarized ZA and 13C urea reference within the tumor mass, overlaid on grayscale anatomical proton MR images. A calibration phantom is visible in the upper right. (c) A spatial mean pH map demonstrates tumor acidity, with a color-coded biosensor pH scale ranging from 7.1 (blue, acidic) to 7.5 (red, basic). The map reveals a lower pH in the extravascular tumor compartment compared to surrounding tissue. (d) 13C NMR spectrum from a tumor voxel showing chemical shifts for ZA peaks (ZA1, ZA5) and urea, indicating two distinct pH environments (7.10 and 7.40). (e) Comparison plots validate the ZA biosensor by correlating results with 31P MRS, optical sensors, and electrode measurements across different compartments (Vena cava, intravascular, and extravascular tumor). This diagnostic imaging research demonstrates ZA's utility as a localized biosensor for assessing the acidic metabolic microenvironment of malignant tumors.

A clinical photograph of a printed arterial blood gas (ABG) analysis report. The document displays measured and calculated physiological values at a patient temperature of 37.0°C. Key measured values include a pH of 7.480, pCO2 of 22.3 mmHg, pO2 of 330.6 mmHg, and electrolyte levels (Na+ 143.4 mmol/L, K+ 3.28 mmol/L, Ca++ 1.03 mmol/L). Calculated values show a bicarbonate (HCO3-) level of 16.8 mmol/L and an oxygen saturation (SO2%) of 100.0%. This visual demonstrates a 'saturation gap' characteristic of certain toxicological conditions, such as methemoglobinemia, where the calculated oxygen saturation from the ABG appears normal (100%) despite the patient potentially experiencing clinical cyanosis and low peripheral pulse oximetry readings. The image is an educational tool for critical care, emergency medicine, and clinical toxicology, illustrating the interpretation of acid-base balance and oxygenation status.

This composite educational graphic demonstrates in vivo metabolic imaging and pH mapping using hyperpolarized 13C magnetic resonance spectroscopy (MRS). The visual elements include axial MRI slices of a rat abdomen with color-coded signal overlays and corresponding quantitative data plots. Panels (a) and (b) show the high signal intensity of zymonic acid (ZA) and 13C-labeled urea concentrated in the kidneys. Panel (c) provides a mean pH map ranging from approximately 6.4 to 7.4, illustrating three distinct physiological compartments: the renal cortex (pH ~7.4, yellow/red), medulla (pH ~6.9, green), and calyx/ureter (pH ~6.5, blue). Panel (e) displays a voxel signal analysis revealing multiple spectral peaks (ZA5, ZA1, PPH5, and Urea). The multi-peak structure for ZA allows for the simultaneous detection of three pH clusters within a single voxel, categorized by chemical shift differences. Panel (f) summarizes the consistency of these pH measurements across different anatomical renal compartments. This material is designed for advanced medical imaging and physiology curricula, focusing on non-invasive metabolic monitoring and biosensor technology.

This composite educational image illustrates the clinical and diagnostic features of distal renal tubular acidosis (dRTA) associated with sensorineural hearing loss. (a) Data table showing results of a bicarbonate loading test, characterized by low urine-to-blood pCO2 gradient and positive urinary anion gap. (b) Renal ultrasound images of the left and right kidneys demonstrating medullary nephrocalcinosis, visualized as multiple hyperechoic foci within the renal pyramids. (c) Axial FIESTA (Fast Imaging Employing Steady-state Acquisition) cerebral MRI scan showing bilateral enlargement of the endolymphatic sacs (indicated by white arrows), a common finding in Pendred syndrome or dRTA with hearing loss. (d) Anatomical schematic of the inner ear, labeling the cochlea, vestibule, semicircular ducts, and endolymphatic duct. (e) Audiogram plot showing frequency (kHz) versus decibels (dB), depicting significant hearing impairment. The collection integrates metabolic laboratory data, diagnostic radiology (ultrasound and MRI), and functional audiological testing to present a comprehensive case of a hereditary renal-otological syndrome.

This diagnostic image is an axial Fluid-Attenuated Inversion Recovery (FLAIR) magnetic resonance imaging (MRI) scan of the brain. The image demonstrates prominent, symmetrical hyperintensities localized within the bilateral basal ganglia, specifically involving the putamina (indicated by white arrows). Additionally, a smaller, heterogeneous area of increased signal intensity is visible in the anterior midline of the cerebral parenchyma. These visual findings are characteristic of bilateral putaminal necrosis, often associated with acute toxic metabolic encephalopathy, such as methanol poisoning. The image highlights key radiological features used in neuroradiology for identifying toxic insults to the deep gray matter structures. It serves as an educational example for medical students and clinicians in identifying specific imaging patterns related to systemic toxicity and high-anion gap metabolic acidosis.

This pathophysiology diagram illustrates the cellular mechanism by which acidosis regulates MondoA transcriptional activity. The schematic is divided into two comparative states: 'Control' (blue background) and 'Acidosis' (red background). Key components include a mitochondrion, Hexokinase 2 (HK2), the MondoA protein, and metabolic intermediates glucose and glucose-6-phosphate (G6P). Under control conditions, mitochondrial ATP (mtATP) levels are low, and HK2 is bound to the outer mitochondrial membrane. Glucose is converted to G6P by HK2, resulting in basal MondoA interaction. In the 'Acidosis' state, a shift in pH drives a significant increase in mtATP production. This high mtATP concentration facilitates enhanced HK2 enzymatic activity at the mitochondrial surface, leading to increased production of G6P. The elevated G6P levels trigger MondoA to undergo nuclear localization and increased transcriptional activity, as indicated by a large upward arrow toward the nucleus. This diagram demonstrates how metabolic sensing of mitochondrial energy charge and cytoplasmic glucose levels are integrated via HK2 to control gene expression under conditions of metabolic stress or altered pH.

This diagnostic comparison image demonstrates the efficacy of respiratory motion compensation in pulmonary C-arm CT imaging. The visual includes three comparative slices (a, b, and c) of a porcine lung phantom scan captured over a 20-second period. Panel (a), labeled 'No compensation,' shows significant motion artifacts where the cross-sections of airways are severely distorted, blurred, and lack clear anatomical definition. Panel (b), labeled 'Compensation,' displays the results of a motion-compensated reconstruction algorithm; the contours of the airways are significantly improved and more accurately positioned, though some residual background noise remains. Panel (c), labeled 'Ground truth,' provides the static reference reconstruction, showing sharp, well-defined airway walls and clear anatomical structures with minimal noise. The comparison illustrates how algorithmic compensation for respiratory motion can restore diagnostic quality in thoracic imaging by reducing artifacts and improving the visibility of fine pulmonary details.

This composite educational image illustrates the methodology and results of respiratory motion compensation in abdominal Magnetic Resonance Imaging (MRI). Panel (a) shows a schematic diagram of a pulse sequence, including a pencil-beam navigator, excitation pulse, and Echo Planar Imaging (EPI) readout synchronized with a respiratory cycle. Panel (b) is a coronal MRI scout image of the liver showing the placement of the navigator on the superior dome. Panel (c) displays a bar graph of navigator signals representing real-time diaphragmatic displacement. Panels (d) and (e) provide a side-by-side comparison of coronal diffusion-weighted images (b=30 s/mm2) acquired over one minute. Image (d) shows significant respiratory motion artifacts, appearing as jagged, discontinuous horizontal bands. In contrast, image (e) demonstrates the efficacy of 'slice following' motion correction, exhibiting smoother, more linear continuity and improved image stability. This content is designed for medical physics and radiology education, focusing on respiratory gating techniques and motion artifact reduction in abdominal imaging.

This infographic presents a feature visualization and model output dashboard for a single patient over a 30-hour Intensive Care Unit (ICU) stay. The top section contains time-series line graphs depicting predicted risk scores (0 to 1) for various clinical conditions, including Mortality, Hypocapnia, Hypercapnia, Hypokalemia, Hyperkalemia, and several types of Acid-Base imbalances (Respiratory/Metabolic Acidosis/Alkalosis). Below the risk scores, a heatmap-style grid displays longitudinal clinical variables, including vital signs (Systolic/Diastolic BP, Heart Rate, SpO2, Respiratory Rate, Temperature), consciousness levels, and laboratory results (Electrolytes, Renal Function, Blood Gas Analysis). Individual cells are color-coded based on SHAP (SHapley Additive exPlanations) values, ranging from blue (negative contribution to risk) to red (positive contribution to risk). This visualization assists in identifying specific physiological trends, such as fluctuating blood pressure and electrolyte imbalances, and provides explainable machine learning insights into which clinical parameters most significantly drive the model’s risk predictions at different time intervals.